🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Intravitreal topotecan exhibits strong anti-inflammatory, anti-proliferativ...
Status
Not Yet Recruiting
Location
St. Michael's Hospital
Start Date
2025-03
Trial ID
NCT06818721
Treatments Being Tested
Retinoblastoma is a childhood cancer which affects the retina of the eye. T...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2005-04-07
Trial ID
NCT00186888
The purpose of this study is to find out whether N10 chemotherapy is a safe...
Status
Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2024-07-22
Trial ID
NCT06528496
Intravitreal topotecan has anti-inflammatory, anti-proliferative and anti-f...
Status
Recruiting
Location
Sunnybrook Health Sciences Centre
Start Date
2023-02-23
Trial ID
NCT05523869
Treatments Being Tested
This study was designed to compare the efficacy and safety of IBB0979 in co...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-08-01
Trial ID
NCT07076095
Treatments Being Tested
To determine the safety profile, maximum tolerated dose (MTD), dose-limitin...
Status
Active Not Recruiting
Location
HonorHealth
Start Date
2019-11-14
Trial ID
NCT04047251
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of Belotec...
Status
Completed
Location
Chungbuk University Hospital
Start Date
2010-09
Trial ID
NCT01497873
This pilot clinical trial studies busulfan, melphalan, and stem cell transp...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2013-04-09
Trial ID
NCT01798004
Treatments Being Tested
This study was designed to compare the efficacy and safety of MHB088C for I...
Status
Recruiting
Location
Shanghai East Hospital
Start Date
2025-06-04
Trial ID
NCT06954246
Treatments Being Tested
This protocol includes 2 independent studies. Both studies are multicenter ...
Status
Recruiting
Location
La Reunion - Chr Felix Guyon
Start Date
2021-03-25
Trial ID
NCT04681417
Treatments Being Tested